1.Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
Yunsong YU ; Weilin ZHOU ; Yagang CHEN ; Yongxiang DING ; Yilin MA
Chinese Medical Journal 2002;115(10):1479-1482
OBJECTIVETo investigate the epidemiological status of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) and the drug resistance profiles of such organisms.
METHODSA total of 282 clinical isolates of E. coli and 180 of K. pneumoniae were collected from different districts of Zhejiang Province. Inhibitor potentiated broth dilution tests were performed for detecting extended-spectrum beta-lactamases. Etests were performed to detect the drug resistance of these strains against nine commonly used antibiotics.
RESULTSThe prevalence of extended-spectrum beta-lactamases in E. coli and K. pneumoniae was 34.0% and 38.3%, respectively. The average prevalence of extended-spectrum beta-lactamases in E. coli and K. pneumoniae was 35.7%. The resistance prevalence of extended spectrum beta-lactamase producing strains to ceftazidime and cefotaxime was 40% and 26% respectively, so were those to cefepime, cefoxitin, piperacillin-tazobactam, cefoperazone-sulbactam, amikacin and ciprofloxacin. All these strains were sensitive to imipenem.
CONCLUSIONThe results in this study showed that the prevalence of extended-spectrum beta-lactamases was high, while extended-spectrum beta-lactamase producing strains were resistant to most antimicrobial agents except imipenem.
Drug Resistance, Bacterial ; Escherichia coli ; drug effects ; enzymology ; Humans ; Klebsiella pneumoniae ; drug effects ; enzymology ; Microbial Sensitivity Tests ; beta-Lactamases ; biosynthesis
2.Emergence of Klebsiella pneumoniae carbapenemase-producing Proteus mirabilis in Hangzhou, China.
Zi-ke SHENG ; Jun-jie LI ; Guo-ping SHENG ; Ji-fang SHENG ; Lan-juan LI
Chinese Medical Journal 2010;123(18):2568-2570
BACKGROUNDCarbapenems are used to treat severe infections caused by multi-drug-resistant organisms, however, the emergence of carbapenem-resistant bacterial isolates is becoming an increasing therapeutic challenge. Since the first Klebsiella (K.) pneumoniae carbapenemase (KPC)-producing K. pneumoniae was reported in 2001, KPC-producing isolates have been found increasingly, specially in Enterobacteriaceae. The aim of this study was to characterize the mechanisms of a carbapenem-resistant Proteus (P.) mirabilis.
METHODSA carbapenem-resistant P. mirabilis isolate was recovered from pleural drainage fluid of a patient admitted to surgical intensive care unit. Antimicrobial susceptibility testing of the isolate was performed by disk diffusion according to Clinical and Laboratory Standards Institute guidelines, and subsequent minimal inhibitory concentrations were determined with the E-test. Amplification of the bla(KPC) gene generated a positive band and the PCR products were sequenced subsequently. The plasmid of the isolate was extracted and was successfully transformed into Escherichia (E.) coli DH5α.
RESULTSThe P. mirabilis isolate was resistant to all detected antimicrobial agents except tigecycline. KPC-2 was confirmed by DNA sequence analysis. The transformant E. coli was resistant to carbapenems. Further study demonstrated that upstream and downstream regions of bla(KPC-2) were identical to that observed in K. pneumoniae submitted to GenBank from China in 2007.
CONCLUSIONCarbapenem resistance in the P. mirabilis isolate in this study is mainly due to production of KPC-2.
Anti-Bacterial Agents ; pharmacology ; Bacterial Proteins ; metabolism ; China ; Klebsiella pneumoniae ; enzymology ; Proteus mirabilis ; drug effects ; enzymology ; beta-Lactamases ; metabolism
3.Evaluation of the Phoenix Automated Microbiology System for Detecting Extended-Spectrum beta-Lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis.
Kyo Kwan LEE ; Sung Tae KIM ; Ki Suk HONG ; Hee Jin HUH ; Seok Lae CHAE
The Korean Journal of Laboratory Medicine 2008;28(3):185-190
BACKGROUND: The aim of this study was to compare the BD Phoenix (Beckton Dickinson Diagnostic Systems, USA) extended-spectrum beta-lactamase (ESBL) test with the Clinical and Laboratory Standards Institute (CLSI) ESBL phenotypic confirmatory test by disk diffusion (CLSI ESBL test) in Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Proteus mirabilis. METHODS: We tested 224 clinical isolates of E. coli, K. pneumoniae, K. oxytoca and P. mirabilis during May 2006 to March 2007. These isolates were examined by the Phoenix and the CLSI ESBL tests simultaneously. For the isolates showing discordant results between the two tests, boronic acid disk test was performed to differentiate AmpC beta-lactamase and ESBL. RESULTS: Among the 224 clinical isolates, 75 and 79 isolates were positive for ESBL by CLSI ESBL test and Phoenix test, respectively. Having detected 4 more isolates as ESBL-producers, Phoenix test showed a 98.2% agreement with a 100% sensitivity and 97.3% specificity compared with CLSI ESBL test. Among the four false positive isolates, three were AmpC-positive but ESBL-negative. CONCLUSIONS: The BD Phoenix ESBL test was sensitive and specific, and can be used as a rapid and reliable method to detect ESBL production in E. coli, Klebsiella species, and P. mirabilis.
Automation
;
Bacterial Proteins/classification/*metabolism
;
Disk Diffusion Antimicrobial Tests
;
Escherichia coli/drug effects/*enzymology/isolation & purification
;
Humans
;
Klebsiella/*enzymology
;
Klebsiella oxytoca/drug effects/enzymology/isolation & purification
;
Klebsiella pneumoniae/drug effects/enzymology/isolation & purification
;
*Microbial Sensitivity Tests
;
Proteus mirabilis/drug effects/*enzymology/isolation & purification
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
beta-Lactamases/classification/*metabolism
4.NDM-1-producing Klebsiella pneumoniae in mainland China.
Ming-Xiang ZOU ; Jing-Min WU ; Jun LI ; Qing-Ya DOU ; Rong-Rong ZHOU ; Yuan HUANG ; Wen-En LIU
Chinese Journal of Contemporary Pediatrics 2012;14(8):616-621
OBJECTIVETo investigate the characteristics of New Delhi metallo-beta-lactamase-1 (NDM-1) gene of Klebsiella pneumoniae (K. pneumoniae) emerging in Hunan, and its relationship to antibiotic resistance.
METHODSThe clinical strain was isolated from a sputum sample of a child with severe pnemonia and toxic myocarditis who was admitted into a general hospital of Hunan Province. VITEK-2 compact instrument was used for bacterial identification and antibiotic susceptibility test. Modified Hodge test was used for the screening of carbapenemase. EDTA-synergy test and combination disk diffusion test were used for detection of metallo-β-lactamase (MBL). PCR was performed for amplification of NDM-1 genes and the positive products were sequenced and analyzed with BLAST. Conjugation was also performed to analyze mechanisms of antibiotic resistance. The results of antibiotic susceptibility tests were compared before and after conjugation.
RESULTSThe isolated strain was identified as K.pneumoniae. Modified Hodge test, EDTA-synergy test and combination disk diffusion test were all positive for the strain. The homology between gene sequence of PCR amplification products and NDM-1 gene FN396876.1 in the GenBank was 100%. Transconjugant DNA was used as template for the amplification of NDM-1 gene. The amplification products were sequenced and found to be the same as the NDM-1 gene amplification product of the donor strain. The MIC of transconjugant E.coli J53 (NDM-1) to all the β-lactams increased significantly compared with the recipient strain E.coli J53. The MIC of ertapenem and imipenem increased by more than 8 times, while the MIC of ceftazidime and ceftriaxone increased by more than 64 times.
CONCLUSIONSThis study first identified a strain of K. pneumoniae carrying NDM-1 in mainland China. NDM-1 gene can be transmitted among different strains and causes extensively drug-resistance to β-lactams.
Base Sequence ; China ; Drug Resistance, Bacterial ; Klebsiella pneumoniae ; drug effects ; enzymology ; genetics ; Molecular Sequence Data ; Polymerase Chain Reaction ; beta-Lactamases ; biosynthesis ; genetics
5.Identification of Klebsiella pneumoniae strains harboring inactive extended-spectrum beta-lactamase antibiotic-resistance genes.
Li XU ; Yao ZHAI ; Yuan LYU ; Qi WANG ; Shuchang AN ; Jichao CHEN ; Yusheng CHEN ; Lin LIU ; Jiabin LI ; Zhancheng GAO
Chinese Medical Journal 2014;127(17):3051-3057
BACKGROUNDThe extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae has increasingly become a major contributor to nosocomial infections and can exhibit multiple antibiotic resistance. Previous studies have focused on the resistance genes in ESBL-producing strains, and the resistance-associated genetic environment of non-ESBL-producing strains has been ignored until now. Here, we investigated the occurrence and characteristics of non-ESBL-producing K. pneumoniae, which potentially carries unexpressed resistance genes.
METHODSK. pneumoniae strains were collected from five medical institutions in China from February 2010 to August 2013. The VITEK-2 ESBL detection system was used as a primary screen to identify the ESBL-producing phenotype, and the three primary types of ESBL-associated genes (CTX, SHV, and TEM) were detected by polymerase chain reaction (PCR) to confirm the strains presenting with a non-ESBL-producing phenotype. mRNA expression in the non-ESBL-producing strains was further screened by reverse-transcription PCR (RT-PCR) to validate their transcriptional efficiency.
RESULTSOut of 224 clinically isolated antibiotic-sensitive K. pneumoniae strains with a non-ESBL-producing phenotype, 5 (2.2%) were identified to carry inactivated ESBL blaSHV genes with intact upstream promoter regions and resistance gene sequences. Interestingly, three of the five antibiotic-sensitive K. pneumoniae strains containing ESBL blaSHV genes still exhibited mRNA transcription of blaSHV, while the other two exhibited no mRNA transcription.
CONCLUSIONThese findings suggest that inactivated ESBL genes exist in non-ESBL-producing antibiotic-sensitive K. pneumoniae strains, which have the potential to transform the strain into an ESBL phenotype if an inappropriate application or overdose of antibiotics is implemented during clinical management.
Anti-Bacterial Agents ; pharmacology ; China ; Drug Resistance, Multiple, Bacterial ; genetics ; Humans ; Klebsiella pneumoniae ; drug effects ; enzymology ; genetics ; Microbial Sensitivity Tests ; beta-Lactamases ; genetics
6.Drug resistance of extended-spectrum-β-lactamases-producing bacteria in children with hematological malignancy after chemotherapy.
Zhuo-Jun ZHENG ; Yong-Min TANG
Chinese Journal of Contemporary Pediatrics 2012;14(7):518-520
OBJECTIVETo study the prevalence and drug resistance of extended-spectrum-β-lactamases (ESBLs)-producing bacteria in blood culture isolated from children with hematological malignancy after chemotherapy.
METHODSBlood samples taken from 3264 children with hematological malignancy and severe infection following chemotherapy between 2002 and 2008 were cultured using the Bact/ALTER 3D blood culture system. VITEK 60 automicroscan was used to identify viral species and to conduct drug resistance tests. The results were indentified according to National Committee for Clinical Laboratory Standard guidelines.
RESULTSFifty-eight strains of Escherichia coli and fifty-one strains of Klebsiella pneumoniae were isolated. Thirty-eight strains of Escherichia coli and nineteen strains of Klebsiella pneumoniae were ESBLs-producing and these ESBLs-producing strains were less susceptible than those that were non-ESBLs-producing to most antibiotics. Both ESBL- and non-ESBL-producing strains were susceptible to imipenem, piperacillin/tazobactam and amikacin.
CONCLUSIONSThe prevalence of ESBLs-producing bacteria is high in childrn with hematological malignancy and infection following chemotherapy. ESBLs-producing bacteria are resistant to common antibiotics, suggesting that antibiotic treatment based on the result of antimicrobial susceptibility test is necessary in these children.
Adolescent ; Bacteremia ; microbiology ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Escherichia coli ; drug effects ; enzymology ; isolation & purification ; Female ; Hematologic Neoplasms ; drug therapy ; microbiology ; Humans ; Klebsiella pneumoniae ; drug effects ; enzymology ; isolation & purification ; Male ; Microbial Sensitivity Tests ; beta-Lactamases ; biosynthesis
7.Clonal Dissemination of Extended-Spectrum beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae Isolates in a Korean Hospital.
Kwan Soo KO ; Joon Sup YEOM ; Mi Young LEE ; Kyong Ran PECK ; Jae Hoon SONG
Journal of Korean Medical Science 2008;23(1):53-60
In this study, we investigated the molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolates that were recovered from an outbreak in a Korean hospital. A new multilocus sequence typing (MLST) scheme for K. pneumoniae based on five housekeeping genes was developed and was evaluated for 43 ESBL-producing isolates from an outbreak as well as 38 surveillance isolates from Korea and also a reference strain. Overall, a total of 37 sequence types (STs) and six clonal complexes (CCs) were identified among the 82 K. pneumoniae isolates. The result of MLST analysis was concordant with that of pulsedfield gel electrophoresis. Most of the outbreak isolates belonged to a certain clone (ST2), and they produced SHV-1 and CTX-M14 enzymes, which was a different feature from that of the K. pneumoniae isolates from other Korean hospitals (ST20 and SHV-12). We also found a different distribution of CCs between ESBL-producing and -nonproducing K. pneumoniae isolates. The MLST method we developed in this study could provide unambiguous and well-resolved data for the epidemiologic study of K. pneumoniae. The outbreak isolates showed different molecular characteristics from the other K. pneumoniae isolates from other Korean hospitals.
Electrophoresis, Gel, Pulsed-Field
;
Hospitals
;
Humans
;
Klebsiella pneumoniae/*classification/enzymology/genetics/isolation & purification
;
Sequence Analysis, DNA
;
beta-Lactamases/*biosynthesis
;
Mycobacteria, Atypical/*drug effects/genetics/isolation & purification
8.A novel LEN-derived beta-lactamase from Klebsiela pneumoniae.
Sheng-wen CHEN ; Ruan-zhang ZHANG ; Yue-mei LU ; Lin HE ; Sha-yan WANG ; Xue-kun MU
Chinese Medical Journal 2005;118(16):1380-1383
9.CTX-M-14, CTX-M-24 and resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates.
Zi-zhong XIONG ; De-mei ZHU ; Fu WANG ; Ying-yuan ZHANG
Chinese Medical Journal 2006;119(2):160-164
Base Sequence
;
Conjugation, Genetic
;
Drug Resistance, Bacterial
;
Electrophoresis, Gel, Pulsed-Field
;
Escherichia coli
;
drug effects
;
enzymology
;
Humans
;
Klebsiella pneumoniae
;
drug effects
;
enzymology
;
Microbial Sensitivity Tests
;
Molecular Sequence Data
;
Polymerase Chain Reaction
;
Transformation, Bacterial
;
beta-Lactamases
;
genetics
10.Detection of drug resistance due to the plasmid-mediated AmpC β-lactamase and genotype analysis in Klebsiella pneumoniae resulting in respiratory infections in children.
Chinese Journal of Pediatrics 2011;49(12):921-925
OBJECTIVETo investigate the production and AmpC β-lactamase in Klebsiella (K.) pneumoniae resulting in respiratory infections in children, AmpC β-Lactamase genotypic resistance and typical resistance to common antibiotics so as to provide some references for selecting drugs in clinical treatment.
METHODMicrobiological identification was performed with the VITEK 60 System, extended spectrum β lactamases (ESBLs) were detected in accordance with the confirmatory test recommended by Clinical and Laboratory Standards Institute (CLSI) and drug sensitivity was determined with Kirby-Bauer method. Suspected positive strains of AmpC β-lactamase were screened with cefoxitin disk diffusion. The genotypes were analyzed by cefoxitin three-dimensional test, conjugation test and PCR sequencing.
RESULTOf the 135 isolates, 30.37% were ESBLs positive, 15.56% were AmpC β-lactamase positive. The positive rates for only AmpC β-Lactamase, both AmpC β-Lactamase and ESBLs, and only ESBLs were 8.15%, 7.41% and 22.96% respectively. The resistant genotypes for AmpC β-Lactamase-positive strains was that 19 strains were of DHA-1 type and 2 were of ACT-1 type. The resistance to drugs in β-lactamase-producing strains was obviously higher than that in non-β-lactamase-producing strains and more serious in those strains producing both AmpC β-Lactamase and ESBLs. Sensitivity of β-lactamase, non-β-lactamase and ESBLs producing strains to imipenem was as high as 100 percent.
CONCLUSIONESBLs- and AmpC-β-lactamase-producing strains of K. pneumoniae resulting in respiratory infections in children in Taizhou city, have a higher detection rate in Taizhou and AmpC-β-lactamase is mainly of DHA-1 genotype. AmpC-β-lactamase- and ESBLs-producing strains are highly resistant, so to restrict the use of β-lactam antibiotics is an important step to reduce the epidemic of β-lactamase-producing strains infection.
Bacterial Proteins ; metabolism ; Child ; Drug Resistance, Multiple, Bacterial ; Genome, Bacterial ; Genotype ; Humans ; Klebsiella Infections ; microbiology ; Klebsiella pneumoniae ; drug effects ; enzymology ; genetics ; Microbial Sensitivity Tests ; Plasmids ; Respiratory Tract Infections ; microbiology ; beta-Lactamases ; metabolism